1. Home
  2. OLMA vs BHB Comparison

OLMA vs BHB Comparison

Compare OLMA & BHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • BHB
  • Stock Information
  • Founded
  • OLMA 2006
  • BHB 1887
  • Country
  • OLMA United States
  • BHB United States
  • Employees
  • OLMA N/A
  • BHB N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • BHB Major Banks
  • Sector
  • OLMA Health Care
  • BHB Finance
  • Exchange
  • OLMA Nasdaq
  • BHB Nasdaq
  • Market Cap
  • OLMA 465.4M
  • BHB 558.4M
  • IPO Year
  • OLMA 2020
  • BHB 1997
  • Fundamental
  • Price
  • OLMA $6.10
  • BHB $31.68
  • Analyst Decision
  • OLMA Strong Buy
  • BHB Hold
  • Analyst Count
  • OLMA 5
  • BHB 2
  • Target Price
  • OLMA $26.25
  • BHB $33.50
  • AVG Volume (30 Days)
  • OLMA 1.1M
  • BHB 38.3K
  • Earning Date
  • OLMA 11-12-2024
  • BHB 01-21-2025
  • Dividend Yield
  • OLMA N/A
  • BHB 3.79%
  • EPS Growth
  • OLMA N/A
  • BHB N/A
  • EPS
  • OLMA N/A
  • BHB 2.78
  • Revenue
  • OLMA N/A
  • BHB $148,706,000.00
  • Revenue This Year
  • OLMA N/A
  • BHB N/A
  • Revenue Next Year
  • OLMA N/A
  • BHB $3.78
  • P/E Ratio
  • OLMA N/A
  • BHB $11.39
  • Revenue Growth
  • OLMA N/A
  • BHB N/A
  • 52 Week Low
  • OLMA $5.56
  • BHB $23.26
  • 52 Week High
  • OLMA $16.78
  • BHB $38.47
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 27.05
  • BHB 30.10
  • Support Level
  • OLMA $5.56
  • BHB $31.07
  • Resistance Level
  • OLMA $6.87
  • BHB $34.70
  • Average True Range (ATR)
  • OLMA 0.81
  • BHB 1.20
  • MACD
  • OLMA -0.28
  • BHB -0.54
  • Stochastic Oscillator
  • OLMA 10.12
  • BHB 9.40

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About BHB Bar Harbor Bankshares Inc.

Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. The company has following reportable segments such as Commercial construction, Commercial real estate owner occupied and non-owner occupied, Tax Exempt, Commercial and industrial loans, Residential real estate, Home equity and Consumer other. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, and fiduciary services, investment planning, education funding, individual retirement planning..

Share on Social Networks: